The Prostate Cancer Prevention Trial (PCPT) was a SWOG-coordinated study designed to test whether the drug finasteride (Proscar®) would prevent prostate cancer in men ages 55 and older. This study was closed on June 24, 2003 because the study objective had been reached. The results of the study, which did find a preventive benefit for the drug, were published as "The Influence of Finasteride on the Development of Prostate Cancer," in the New England Journal of Medicine on July 17, 2003.
You can view the list of projects that have been awarded use of these biorepository resources through a peer-review process.
The following resources provide information about PCPT and its biorepository.
Biorepository resources from the Selenium and Vitamin E Cancer Trial (SELECT), which also studied prostate cancer prevention, are also available.
- Summary of PCPT trial and results (PDF)
- Summary of P01 grant and other approved or funded projects based on PCPT (PDF)
- Additional PCPT documents
- PCPT data (all collapsed over arms)